Cargando…
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139756/ https://www.ncbi.nlm.nih.gov/pubmed/35626757 http://dx.doi.org/10.3390/cells11101700 |
_version_ | 1784714932840824832 |
---|---|
author | Zakrzewicz, Anna Würth, Celina Beckert, Benedikt Feldhoff, Simon Vanderheyden, Katrien Foss, Stian Andersen, Jan Terje de Haard, Hans Verheesen, Peter Bobkov, Vladimir Tikkanen, Ritva |
author_facet | Zakrzewicz, Anna Würth, Celina Beckert, Benedikt Feldhoff, Simon Vanderheyden, Katrien Foss, Stian Andersen, Jan Terje de Haard, Hans Verheesen, Peter Bobkov, Vladimir Tikkanen, Ritva |
author_sort | Zakrzewicz, Anna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9139756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91397562022-05-28 Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 Zakrzewicz, Anna Würth, Celina Beckert, Benedikt Feldhoff, Simon Vanderheyden, Katrien Foss, Stian Andersen, Jan Terje de Haard, Hans Verheesen, Peter Bobkov, Vladimir Tikkanen, Ritva Cells Correction MDPI 2022-05-20 /pmc/articles/PMC9139756/ /pubmed/35626757 http://dx.doi.org/10.3390/cells11101700 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Correction Zakrzewicz, Anna Würth, Celina Beckert, Benedikt Feldhoff, Simon Vanderheyden, Katrien Foss, Stian Andersen, Jan Terje de Haard, Hans Verheesen, Peter Bobkov, Vladimir Tikkanen, Ritva Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title | Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title_full | Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title_fullStr | Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title_full_unstemmed | Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title_short | Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942 |
title_sort | correction: zakrzewicz et al. stabilization of keratinocyte monolayer integrity in the presence of anti-desmoglein-3 antibodies through fcrn blockade with efgartigimod: novel treatment paradigm for pemphigus? cells 2022, 11, 942 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139756/ https://www.ncbi.nlm.nih.gov/pubmed/35626757 http://dx.doi.org/10.3390/cells11101700 |
work_keys_str_mv | AT zakrzewiczanna correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT wurthcelina correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT beckertbenedikt correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT feldhoffsimon correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT vanderheydenkatrien correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT fossstian correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT andersenjanterje correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT dehaardhans correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT verheesenpeter correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT bobkovvladimir correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 AT tikkanenritva correctionzakrzewiczetalstabilizationofkeratinocytemonolayerintegrityinthepresenceofantidesmoglein3antibodiesthroughfcrnblockadewithefgartigimodnoveltreatmentparadigmforpemphiguscells202211942 |